Spring Bank initiates phase I study of SB-11285 alone and with nivolumab in solid tumors Oct. 18, 2019
FDA approves Xofluza to treat influenza in those at high risk of influenza complications Oct. 18, 2019
New potent and selective ROS1/TRK family inhibitor is effective in crizotinib-resistant models Oct. 18, 2019
TAP downregulation by an aptamer-siRNA conjugate could potentiate responsiveness to immune therapy Oct. 18, 2019
Shanghai Institute of Materia Medica and Jinan University patent AXL and/or FLT3 inhibitors Oct. 18, 2019
New apoptosis regulator Bcl-2 inhibitors disclosed by Jiangsu Chia Tai Tianqing Pharmaceutical Group Oct. 18, 2019
RSS